Palisade Bio Inc. Common Stock is a biotechnology company focused on the development of innovative therapies for chronic diseases. With a strong pipeline of drug candidates targeting gastrointestinal disorders, the company aims to provide effective and safe treatments for patients worldwide. Through its cutting-edge research and development efforts, Palisade Bio Inc. Common Stock is poised to make a significant impact on the healthcare industry.
